Market revenue in 2020 | USD 250.3 million |
Market revenue in 2028 | USD 572.2 million |
Growth rate | 10.9% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Software & Services |
Key market players worldwide | Diasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 66.2% in 2020. Horizon Databook has segmented the India chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
In India, testing for infectious diseases has led to an increase in the demand for CLIA products. Rise in the prevalence of sexually transmitted diseases, ventilator-acquired pneumonia, tuberculosis, and hospital-acquired infections is one of the factors driving the market growth in India.
Presence of well-distributed network of clinical laboratories in India is leading to higher and faster adoption of CLIA solutions. Although testing is costlier in the country and affordable only to upper-tier economic group, rapid economic development of the nation has dramatically increased the purchasing capacity.
Moreover, high demand for better diagnosis and preventive medicine is expected to drive the market growth in India.
Horizon Databook provides a detailed overview of country-level data and insights on the India chemiluminescence immunoassay market , including forecasts for subscribers. This country databook contains high-level insights into India chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account